Poverty and Illiteracy: Reasons Why India Is Conned Into Clinical Trials

According to the estimate given by the Confederation of Indian Industry, clinical trials is a booming business in India as the companies save almost 60 percent by taking up various new drugs testing in India as compared to other developed nations.

This illegal trade which risk human lives has come to light because of the legal case which began in February last year and it involved doctors and the pharmaceutical companies.

Amulya Nidhi one of the health campaigners of Swasthya Adhikaar Manch group is of the opinion that the lack of rules and regulations has instigated all these companies to pick India and other developing nations for such acts.

She further stated "In Europe and the United States the laws are pretty strict. India, on the other hand, makes for a less restrictive destination for drug trials because the regulator lacks teeth."

The government after facing outpoured criticisms from all corners of the country is all set to amend the old Drugs and Cosmetics Act with an aim to instill greater responsibility on companies and ethics committees which are supposed to look into the trials.